Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elsken van der Wall

Showing results (1-10 of 186) with videos related to

Pageof 19
Sort By:
Clinical Breast Cancer|September 24, 2021
Endocrine Therapy With or Without CDK4/6 Inhibitors in Women With Hormone-receptor Positive Breast Cancer: What do we Know About the Effects on Cognition?Philippe R Lee Meeuw Kjoe, Elsken van der Wall, Sanne B Schagen
Cellular Oncology (Dordrecht, Netherlands)|February 22, 2011
Pathology of hereditary breast cancerPetra van der Groep, Elsken van der Wall, Paul J van Diest
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 18, 2012
Testing for discordance at metastatic relapse of breast cancer mattersPaul J van Diest, Laurien D C Hoefnagel, Elsken van der Wall
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
EGFR expression predicts BRCA1 status in patients with breast cancerPaul J van Diest, Petra van der Groep, Elsken van der Wall
Human Pathology|July 27, 2006
p300 and p53 levels determine activation of HIF-1 downstream targets in invasive breast cancerMarije M Vleugel, David Shvarts, Elsken van der Wall, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 17, 2009
Obesity and cancer: the role of dysfunctional adipose tissueRob C M van Kruijsdijk, Elsken van der Wall, Frank L J Visseren
Expert Opinion on Investigational Drugs|April 17, 2013
Antimitotic agents for the treatment of patients with metastatic castrate-resistant prostate cancerMichel D Wissing, Paul J van Diest, Elsken van der Wall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2013
Explicit prognostic information and reassurance about nonabandonment when entering palliative breast cancer care: findings from a scripted video-vignette studyLiesbeth M van Vliet, Elsken van der Wall, Nicole M Plum, et al.
Cellular Oncology (Dordrecht, Netherlands)|July 7, 2011
Subcellular FIH-1 expression patterns in invasive breast cancer in relation to HIF-1α expressionAgon Hyseni, Petra van der Groep, Elsken van der Wall, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|June 12, 2008
Molecular analysis of nipple fluid for breast cancer screeningKarijn P M Suijkerbuijk, Elsken van der Wall, Marc Vooijs, et al.
Pageof 19

Showing results (1-10 of 186) with videos related to

Sort By:
Pageof 19
Clinical Breast Cancer|September 24, 2021
Endocrine Therapy With or Without CDK4/6 Inhibitors in Women With Hormone-receptor Positive Breast Cancer: What do we Know About the Effects on Cognition?Philippe R Lee Meeuw Kjoe, Elsken van der Wall, Sanne B Schagen
Cellular Oncology (Dordrecht, Netherlands)|February 22, 2011
Pathology of hereditary breast cancerPetra van der Groep, Elsken van der Wall, Paul J van Diest
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 18, 2012
Testing for discordance at metastatic relapse of breast cancer mattersPaul J van Diest, Laurien D C Hoefnagel, Elsken van der Wall
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
EGFR expression predicts BRCA1 status in patients with breast cancerPaul J van Diest, Petra van der Groep, Elsken van der Wall
Human Pathology|July 27, 2006
p300 and p53 levels determine activation of HIF-1 downstream targets in invasive breast cancerMarije M Vleugel, David Shvarts, Elsken van der Wall, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 17, 2009
Obesity and cancer: the role of dysfunctional adipose tissueRob C M van Kruijsdijk, Elsken van der Wall, Frank L J Visseren
Expert Opinion on Investigational Drugs|April 17, 2013
Antimitotic agents for the treatment of patients with metastatic castrate-resistant prostate cancerMichel D Wissing, Paul J van Diest, Elsken van der Wall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2013
Explicit prognostic information and reassurance about nonabandonment when entering palliative breast cancer care: findings from a scripted video-vignette studyLiesbeth M van Vliet, Elsken van der Wall, Nicole M Plum, et al.
Cellular Oncology (Dordrecht, Netherlands)|July 7, 2011
Subcellular FIH-1 expression patterns in invasive breast cancer in relation to HIF-1α expressionAgon Hyseni, Petra van der Groep, Elsken van der Wall, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|June 12, 2008
Molecular analysis of nipple fluid for breast cancer screeningKarijn P M Suijkerbuijk, Elsken van der Wall, Marc Vooijs, et al.
Pageof 19